Georgia Research Alliance logo

Georgia Research Alliance

North America, Georgia, United States, Atlanta

Description

The Georgia Research Alliance (GRA) is a distinctive non-profit organization based in Atlanta, Georgia, dedicated to expanding the research and commercialization capacity within the state's universities. Established in 1990, GRA plays a pivotal role in transforming groundbreaking academic discoveries into viable businesses, thereby fostering economic growth and job creation across Georgia. Its core mission involves recruiting world-class scientists, investing in state-of-the-art research infrastructure, and, critically, providing the necessary capital to launch university-born startups.

Through its GRA Ventures program, the alliance acts as a crucial early-stage investor for companies emerging from Georgia's leading research institutions. GRA Ventures specifically targets startups that are based on university intellectual property and led by experienced entrepreneurs, often serving as the very first institutional investor. The organization typically provides seed funding, with initial investments generally ranging between $150,000 and $500,000. These investments are commonly structured as convertible notes or direct equity, providing essential capital for nascent companies to develop their products, build their teams, and secure further private funding.

GRA's strategic investments have yielded substantial economic impact for the state. Since its inception, the Georgia Research Alliance has been instrumental in helping to launch more than 200 companies, demonstrating a consistent commitment to nurturing innovative ventures. These portfolio companies have collectively attracted over $2.1 billion in private investment, a testament to the quality of the research and the commercial potential identified by GRA. Furthermore, these ventures have contributed significantly to job creation, generating more than 7,900 jobs within Georgia. GRA's unique model effectively bridges the gap between academic research and market commercialization, solidifying Georgia's position as a hub for scientific innovation and entrepreneurial success.

Investor Profile

Georgia Research Alliance has backed more than 154 startups, with 0 new investments in the last 12 months alone. The firm has led 142 rounds, about 92% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Seed, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Australia, Sweden.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Typical check size: $150K – $500K.

Stage Focus

  • Grant (92%)
  • Seed (3%)
  • Series A (2%)
  • Debt Financing (1%)
  • Series E (1%)
  • Series B (1%)
  • Series C (1%)

Country Focus

  • United States (76%)
  • Australia (4%)
  • Sweden (3%)
  • France (3%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Medical Device
  • Pharmaceutical
  • Health Diagnostics
  • Biopharma
  • Life Science
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Georgia Research Alliance frequently co-invest with?

Vensana Capital
North America, Minnesota, United States, Minneapolis
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
RMI Partners
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Broadview Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
GRA Venture Fund
North America, Georgia, United States, Atlanta
Co-Investments: 1
Epidarex Capital
North America, Maryland, United States, Bethesda
Co-Investments: 1
Masters Capital Management
North America, Georgia, United States, Atlanta
Co-Investments: 1
Bio/Med Investor Network
North America, Georgia, United States, Atlanta
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1

Which angels does Georgia Research Alliance often collaborate with?

BM
North America, New Jersey, United States, Newark
Shared Deals: 1
PB
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1

What are some of recent deals done by Georgia Research Alliance?

Nyra Medical

Atlanta, Georgia, United States

Nyra Medical develops a catheter-plug technology to repair a leaky mitral valve in the heart.

Medical Device
Series ANov 18, 2022
Amount Raised: $20,000,000
EarliTec Diagnostics

Decatur, Georgia, United States

EarliTec Diagnostics makes early autism diagnosis and treatment accessible to every child, everywhere.

ChildrenHealth Care
Series AFeb 18, 2022
Amount Raised: $19,500,000
Oncospherix

Atlanta, Georgia, United States

Oncospherix is the culmination of a multi-year research program for cancer.

Clinical TrialsHealth CareMedicalPharmaceutical
Debt FinancingSep 1, 2021
Amount Raised: $250,000
TendoNova

Suwanee, Georgia, United States

TendoNova is a medical technology company providing systems for office-based orthopedic procedures to address tendon injury and pain.

BiotechnologyHealth CareManufacturingMedical
Debt FinancingAug 5, 2021
Amount Raised: $250,000
Oncospherix

Atlanta, Georgia, United States

Oncospherix is the culmination of a multi-year research program for cancer.

Clinical TrialsHealth CareMedicalPharmaceutical
GrantAug 2, 2021
Amount Raised: $46,666
Oncospherix

Atlanta, Georgia, United States

Oncospherix is the culmination of a multi-year research program for cancer.

Clinical TrialsHealth CareMedicalPharmaceutical
GrantFeb 2, 2021
Amount Raised: $53,334

Aviabiotic creates probiotics for integrated poultry companies.

AgricultureBiotechnologyGeneticsHealth CareLivestock
GrantMar 18, 2020
Amount Raised: $20,000
AngioCloud

Atlanta, Georgia, United States

AngioCloud allows medical professionals to share and analyze 3D vascular images with unprecedented ease and flexibility.

3D TechnologyCloud ComputingHealth CareMedicalMedical DeviceSoftware
GrantMar 2, 2020
Amount Raised: $34,257

Neovaccine Strategies develops a novel immunotherapeutic reagent to act as a prophylactic against P. aeruginosa.

BiotechnologyLife SciencePharmaceutical
GrantMar 2, 2020
Amount Raised: $24,665
Focused Cryo

Kennesaw, Georgia, United States

Focused Cryo is a healthcare company that develops a smart cryoablation system that provides better spatiotemporal control.

Health CareMedicalMedical Device
GrantFeb 10, 2020
Amount Raised: $70,000